A Four Month Home Based tDCS Study on Patients With Alzheimer's Disease. (tDCS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04759092|
Recruitment Status : Recruiting
First Posted : February 18, 2021
Last Update Posted : February 18, 2021
|Condition or disease||Intervention/treatment||Phase|
|Alzheimer Disease||Device: transcranial direct current stimulation (tDCS)||Not Applicable|
Active tDCS of 2mA is applied via surface based electrodes daily for 30 minutes over a 4 month period. Anodal electrode is placed over the left temporal lobe. Participants is followed up by home visit and phone calls.
Cognitive tests are performed prior to the treatment period, right after finishing 4 months of treatment and 4 months after treatment is terminated.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||8 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||Treatment study, open label|
|Masking:||None (Open Label)|
|Official Title:||A Four Month Home Based tDCS Study on Patients With Alzheimer's Disease.|
|Actual Study Start Date :||April 1, 2019|
|Estimated Primary Completion Date :||April 1, 2021|
|Estimated Study Completion Date :||April 1, 2021|
Experimental: Treatment with tDCS
Home based treatment with tDCS for four months
Device: transcranial direct current stimulation (tDCS)
Apply 30min low dose (2mA) transcranial current stimulation on the scalp every day for four months.
Other Name: tDCS
- To investigate tolerability [ Time Frame: 4 months ]Investigation of tolerability of long term home based tDCS to patients with Alzheimer's by using the Adverse effect questionnaire for tDCS
- To investigate effect of the treatment [ Time Frame: 8 months ]Investigate possible change in cognitive tests (Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), Mini Mental Status Examination ( MMSE), Clock drawing test, Trail making test A & B) after 4 months treatment and change 4 months after end of treatment
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04759092
|Contact: Ole Kristian Grønli, MD/PHDemail@example.com|
|University Hospital of North Norway||Recruiting|
|Tromsø, Troms, Norway, 9091|
|Contact: Ole Kristian Grønli, MD/Phd +4777627793 firstname.lastname@example.org|
|Principal Investigator:||Ole K Grønli Grønli, MD/PHD||University Hospital of North Norway|